Company Overview and News
Hong Kong property developers have shown keen interest in bidding for a plot of land atop the MTR station in Wong Chuk Hang, even as the government is poised to released its policy position on the proposed vacancy tax, which would encourage companies to clear their stock of completed, but unsold flats.
SUHJY 0016 SHGKF 0129 2007 SHGKY MTRJY 0083 ASASF 0012 SUHJF
The city is one the world’s least and most green cities – only a fraction of 40,000 buildings are green but over 75pc of land has been left in a relatively natural state
SUHJY 0017 0016 SHGKF 1972 SWROY SHGKY SWPFF 0083 SUHJF
Urban Renewal Authority, which received bids from 20 companies for a redevelopment project in Sham Sui Po, will for the first time reveal the winning bid and an anonymous list of submitted bid values
EPRRY SUHJY 0016 SHGKF M35 SHGKY 0163 0083 0230 SUHJF
K Wah Group will soon announce details of its 1,122-unit Solaria development in Pak Shek Kok, while Sun Hung Kai Properties and Billion Development are also gearing up to launch their respective projects
SUHJY 0016 SHGKF SHGKY 0041 0083 GEAHF SUHJF
One of the city’s largest land owners won the 14th government tender by paying a record HK$25.1 billion for a plot with gross floor area of 1.42 million sq ft
SHGKY KRYPY 0086 LFSYF 0083 1212 0683 0012 SUHJF SUHJY 0016 SHGKF 0813 M35 SHMAY SIOPF KRYPF LFSYY
Developers are forming consortiums to spread the financial risk of bidding for a residential site that could fetch an estimated US$3.25 billion
SHGKY KRYPY LFSYF 0083 1212 0683 0012 SUHJF SUHJY 0016 SHGKF M35 KRYPF LFSYY
Once touted as ‘Richard Li’s right-hand man’, does one of Hong Kong’s savviest deal makers have what it takes to found a new property empire to rival that of Henderson or New World?
0017 STAN 0432 580001 STAB STAN STAC 2888 SCBFF CPSDF 0083
The tender for a non-industrial site in Tsing Yi attracted 25 bids on Friday, with developers ignoring the site’s location and small size in a sign of hunger for land in the world’s most expensive city.
M35 MTRJY 0083
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...